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We have studied hemoglobin concentration in saliva of
anti-HIV positive and anti-HIV negative intravenous drug
abusers (IVDA) and normal controls and the relationship
between hemoglobin concentration in saliva and number
of CD4+ cells and clinical status of AIDS in anti-HIV pos-
itive IVDA. 120 anti-HIV positive IVDA' 112 anti-HIV neg-
ative IVDA and 116 normal healthy subJects not
belonging to any risk group for HIV infection completed
the study. Saliva was collected at awakening before brush-
ing teeth and the concentration of hemoglobin was deter-
mined. Hemoglobin concentration in saliva in basal
conditions is higher in anti-HIV positive IVDA with
respect to anti-HIV negative IVDA (p less than 0.05) and
controls (p less than 0.01). In anti-HIV positive IVDA
hemoglobin concentration in saliva is higher in subjects
with CD4+ cells less than 200/10(6) l with respect to sub-
jects with CD4+ greater than 200/10(6) l (p less than
0.05) and in subjects with ARC/AIDS with respect to sub-
jects with PGL or who are asymptomatic (p less than
0.01). SubJects with ARC/AIDS have a mean concentra-
tion of hemoglobin of 19 micrograms/0.1 ml saliva
(range 0–153) which corresponds to 1.3 microliters of
blood/ml saliva. If 10 ml of saliva are exchanged during
kissing an average of 13 microliters of blood are trans-
ferred (110 microliters of whole blood at extreme range).
Blood of symptomatic patients has an HIV titer of 7 TCID/
microliters which for 10 ml saliva containing an average
of 1.3 microliters blood/ml saliva corresponds to an aver-
age of 90 TCID (770 TCID at the extreme range).
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